The Claim
Inhibition of nitric oxide does not alter coronary vasodilation induced by sodium nitroprusside and adenosine, indicating that nitric oxide's role is restricted to endothelium-dependent vasodilatory pathways.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Blocking nitric oxide does not change how coronary arteries widen when sodium nitroprusside or adenosine is applied, showing that nitric oxide is not involved in these specific dilation mechanisms.
See the scientific wording
Nitric oxide inhibition does not affect coronary vasodilation in response to endothelium-independent vasodilators sodium nitroprusside and adenosine, confirming that its effect is specific to endothelium-dependent pathways.
When the heart needs more oxygen, blood flow increases and pushes against the inner lining of coronary arteries. This push activates the lining to make nitric oxide, which travels to the muscle layer around the artery and tells it to relax, widening the artery and letting more blood through. Drugs that directly release nitric oxide or act on the muscle without touching the lining bypass this step and still cause widening, even when the lining is blocked.
What the research says
1 studyStudy: Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Blocking nitric oxide stopped the heart's blood vessels from widening when a substance that needs the inner lining to work was used, but it didn’t stop them from widening when drugs were used that work directly — proving nitric oxide only works through the inner lining.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.